Short-term outcomes of Quebec's ban on flavoured vaping products on adolescent electronic cigarette use: a 2022-2024 COMPASS longitudinal analysis.

IF 2.6 4区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Canadian Journal of Public Health-Revue Canadienne De Sante Publique Pub Date : 2026-04-28 DOI:10.17269/s41997-026-01199-6

Slim Haddad, Richard E Bélanger, Natalia Poliakova, Rabi Joël Gansaonré, Scott T Leatherdale

{"title":"Short-term outcomes of Quebec's ban on flavoured vaping products on adolescent electronic cigarette use: a 2022-2024 COMPASS longitudinal analysis.","authors":"Slim Haddad, Richard E Bélanger, Natalia Poliakova, Rabi Joël Gansaonré, Scott T Leatherdale","doi":"10.17269/s41997-026-01199-6","DOIUrl":null,"url":null,"abstract":"Objectives: Studies evaluating the outcomes of flavoured vaping product sales bans on adolescent vaping remain scarce, often inconclusive, and of limited generalizability, as they rely predominantly on US data. This study examines the short-term outcomes of such legislation implemented in Quebec (Canada) in October 2023.Methods: A pretest-posttest design with a nonequivalent control group was used, drawing on data from the 2022, 2023 (pre-intervention), and 2024 (post-intervention) waves of the COMPASS study. The exposed group included 4540 adolescents from 68 Quebec schools, and the comparison group included 1491 adolescents from 39 Ontario schools. Indicators derived from self-reported current vaping (past-30-days) were analysed: non-use, daily use, initiation, reduction, mean magnitude of reduction, and cessation.Results: Between 2023 and 2024, difference-in-differences analyses revealed no significant between-group differences across all six outcomes examined: non-use (-0.7 percentage point; 95% CI [-2.4, 1.1]), daily use (+ 0.6 point; [-0.2, 1.4]), initiation (+ 1.6 point; [-1.1, 4.3]), reduced use (-9.7 points; [-20.7, 1.3]), mean magnitude of use reduction (+ 0.3 points on the ordinal scale; [-0.1, 0.7]), and cessation (-3.6 points; [-14.9, 7.8]).Conclusion: The results do not provide evidence of short-term outcomes of the Quebec legislation and suggest the need for adjusted approaches. Such adjustments may involve strengthening both the design and implementation of interventions. Future research with longer follow-up periods is needed to identify the most effective measures to protect adolescents.","PeriodicalId":51407,"journal":{"name":"Canadian Journal of Public Health-Revue Canadienne De Sante Publique","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Public Health-Revue Canadienne De Sante Publique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17269/s41997-026-01199-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: Studies evaluating the outcomes of flavoured vaping product sales bans on adolescent vaping remain scarce, often inconclusive, and of limited generalizability, as they rely predominantly on US data. This study examines the short-term outcomes of such legislation implemented in Quebec (Canada) in October 2023.

Methods: A pretest-posttest design with a nonequivalent control group was used, drawing on data from the 2022, 2023 (pre-intervention), and 2024 (post-intervention) waves of the COMPASS study. The exposed group included 4540 adolescents from 68 Quebec schools, and the comparison group included 1491 adolescents from 39 Ontario schools. Indicators derived from self-reported current vaping (past-30-days) were analysed: non-use, daily use, initiation, reduction, mean magnitude of reduction, and cessation.

Results: Between 2023 and 2024, difference-in-differences analyses revealed no significant between-group differences across all six outcomes examined: non-use (-0.7 percentage point; 95% CI [-2.4, 1.1]), daily use (+ 0.6 point; [-0.2, 1.4]), initiation (+ 1.6 point; [-1.1, 4.3]), reduced use (-9.7 points; [-20.7, 1.3]), mean magnitude of use reduction (+ 0.3 points on the ordinal scale; [-0.1, 0.7]), and cessation (-3.6 points; [-14.9, 7.8]).

Conclusion: The results do not provide evidence of short-term outcomes of the Quebec legislation and suggest the need for adjusted approaches. Such adjustments may involve strengthening both the design and implementation of interventions. Future research with longer follow-up periods is needed to identify the most effective measures to protect adolescents.

查看原文本刊更多论文

魁北克禁止调味电子烟产品对青少年电子烟使用的短期影响：2022-2024年COMPASS纵向分析。

目的：由于主要依赖于美国的数据，评估调味电子烟产品销售禁令对青少年电子烟的影响的研究仍然很少，往往是不确定的，而且泛化性有限。本研究考察了2023年10月在加拿大魁北克省实施的此类立法的短期结果。方法：采用前测后测设计，采用非等效对照组，采用COMPASS研究的2022、2023（干预前）和2024（干预后）波数据。暴露组包括来自魁北克68所学校的4540名青少年，对照组包括来自安大略省39所学校的1491名青少年。从自我报告的当前电子烟（过去30天）中得出的指标进行了分析：不使用，每天使用，开始使用，减少，平均减少幅度和戒烟。结果：在2023年至2024年期间，差异中差异分析显示，在所检查的所有六个结果中，组间差异均不显著：不使用（-0.7个百分点；95% CI[-2.4, 1.1]）、每日使用（+ 0.6个百分点；[-0.2,1.4]）、开始使用（+ 1.6个百分点；[-1.1,4.3]）、减少使用（-9.7个百分点；[-20.7,1.3]）、减少使用的平均幅度（在顺序量表上+ 0.3个百分点；[-0.1,0.7]）和戒烟（-3.6个百分点；[-14.9,7.8]）。结论：结果不能提供魁北克立法的短期结果的证据，并建议需要调整方法。这种调整可能涉及加强干预措施的设计和执行。未来需要更长的随访期进行研究，以确定保护青少年的最有效措施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Canadian Journal of Public Health-Revue Canadienne De Sante Publique PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

6.10

自引率

4.70%

发文量

128

期刊介绍： The Canadian Journal of Public Health is dedicated to fostering excellence in public health research, scholarship, policy and practice. The aim of the Journal is to advance public health research and practice in Canada and around the world, thus contributing to the improvement of the health of populations and the reduction of health inequalities. CJPH publishes original research and scholarly articles submitted in either English or French that are relevant to population and public health. CJPH is an independent, peer-reviewed journal owned by the Canadian Public Health Association and published by Springer. Énoncé de mission La Revue canadienne de santé publique se consacre à promouvoir l’excellence dans la recherche, les travaux d’érudition, les politiques et les pratiques de santé publique. Son but est de faire progresser la recherche et les pratiques de santé publique au Canada et dans le monde, contribuant ainsi à l’amélioration de la santé des populations et à la réduction des inégalités de santé. La RCSP publie des articles savants et des travaux inédits, soumis en anglais ou en français, qui sont d’intérêt pour la santé publique et des populations. La RCSP est une revue indépendante avec comité de lecture, propriété de l’Association canadienne de santé publique et publiée par Springer.